Clinical trial
The Value of Routine Screening for Diffuse Vascular Disease in the Canadian Post-Acute Coronary Syndrome/Ischemic Stroke/Transient Ischemic Attack General Practice Population With Previously Undocumented Peripheral Arterial Disease
NCT01076738 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Value of Routine Screening for Diffuse Vascular Disease in the Canadian Post-Acute Coronary Syndrome/Ischemic Stroke/Transient Ischemic Attack General Practice Population With Previously Undocumented Peripheral Arterial Disease
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- June 30, 2010
- Enrollment
- 2,233 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.